drugset / Trial / NCT00604656
Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the safety and efficacy of insulin aspart produced by current process compared to that of insulin aspart produced by NN2000 process in subjects with type 2 diabetes.
Timeline
- Start
- 2003-05-05
- Primary completion
- 2004-01-29
- Completion
- 2004-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | — | — |